Meningococcal Vaccines Market Share, Size, Growth And Segment Forecasts To 2020

Market Reports Center
One Stop Market Reaserch Shop
Meningococcal Vaccines Market Share, Size, Emerging Trends and
Growth, Analysis, Overview and Forecasts 2016-2020
Technavio Announces the Publication of its Research Report – Global Meningococcal Vaccines Market
2016-2020
Technavio recognizes the following companies as the key players in the global meningococcal vaccines
market: GSK, Sanofi, and Pfizer.
Other Prominent Vendors in the market are Beijing Minhai Biotechnology, Bio Med, Hualan Biological
Engineering, Imunoloski Zavod, JN International Medical, Nuron Biotech, Serum Institute of India,
Vacunas Finlay, Merck, GlycoVaxyn, and Baxter.
Commenting on the report, an analyst from Technavio’ s team said that the availability of combination
vaccines is one of the key trends aiding to the growth of this market. Bacterial meningitis is caused by
bacteria such as Haemophilus influenzae type B, meningococci, and pneumococci. Combination vaccines
for meningitis target multiple causative agents, thereby preventing meningitis caused by these agents.
For instance, Menhibrix is approved to prevent invasive meningococcal disease caused by Haemophilus
influenzae type b and Neisseria meningitidis serogroups C and Y. Thus, combination vaccines eliminate
the need to administer individual vaccines. The lower the number of injections administered, the lower
the frequency of injection site reactions, such as pain, increasing patient compliance. Increased
compliance results in effective prevention of the disease. Combination vaccines also decrease the
packaging and transportation expenditure associated with multiple individual vaccines. Collectively,
these factors decrease the development and marketing costs of the vaccine and increase the market
revenue by effective prevention of the disease.
Market Reports Center
One Stop Market Reaserch Shop
Browse full report with TOC@
meningococcal-vaccines-market-2016-2020
https://marketreportscenter.com/reports/344085/global-
According to the report, the increase in awareness about vaccination and immunization programs will
lead to the growth of this market. The WHO conducted a program in over 180 countries in 2013 under
the slogan 'Protect your world - get vaccinated'. In 2015, the organization celebrated the European
Immunization Week from April 22nd-26th. Every year, the last week of April is observed as the World
Immunization Week as per the WHO mandate. In the US, the Association of American Physicians (AAP)
and the National Institute of Agricultural Marketing (NIAM) helped increase vaccination coverage in the
region. The Amanda Young Foundation is dedicated to reducing the number of deaths from
meningococcal disease in Western Australia by organizing activities such as summits and fundraising
events to raise awareness about the disease. The foundation also provides funds to support new and
ongoing research on the disease.
Further, the report states that vaccine storage and handling issues is one of the major challenges,
decreasing the sales of the vaccine in countries with poor affordability. Vaccines require cold conditions
to stay efficacious and are likely to lose their potency if the temperature drops below 35.6 degrees
Fahrenheit or goes above 46.4 degrees Fahrenheit. Inadequately stored vaccines lose their efficacy and
can cause increased local reactions. Though loss of effectiveness is irreversible, it leads to wastage of
vaccine and resources. Thus, the temperature should be maintained at every step of the distribution
chain to ensure the supply of potent vaccines. Cold storage requires special machinery and care, which
increases the market price of vaccines.
The study was conducted using an objective combination of primary and secondary information
including inputs from key participants in the industry. The report contains a comprehensive market and
vendor landscape in addition to a SWOT analysis of the key vendors.
Request A Sample copy of This Report @ https://marketreportscenter.com/request-sample/344085
Meningitis (meningococcal diseases) is characterized by inflammation of the protective lining (meninges)
present around the brain and spinal cord. It can be classified into infectious and non-infectious
meningitis. Based on the types of organism, infectious meningitis is sub-divided into bacterial meningitis,
viral meningitis, fungal meningitis, and parasitic meningitis. Bacterial meningitis occurs due to bacterial
species such as hemophilus influenzae, listeria monocytogenes, neisseria meningitidis, and
streptococcus pneumoniae.
Technavio’ s analysts forecast the global meningococcal vaccines market to grow at a CAGR of 13.07%
during the period 2016-2020.
Market Reports Center
One Stop Market Reaserch Shop
Covered in this report
The report covers the present scenario and the growth prospects of the global meningococcal vaccines
market for 2016-2020. To calculate the market size, the report considers the the report considers the
revenue generated from the sales of vaccines used to prevent meningococcal infections.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Meningococcal Vaccines Market 2016-2020, has been prepared based on an
in-depth market analysis with inputs from industry experts. The report covers the market landscape and
its growth prospects over the coming years. The report also includes a discussion of the key vendors
operating in this market.
To Get Discount On The Report @ https://marketreportscenter.com/request-discount/344085
Connect for more details:
Sam Collins
Market Reports Center
1-646-883-3044 (US)
info@marketreportscenter.com